7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy

      1 , 2 , 1 , 2 , 3 , 4 , 5 , 6 , 4 , 5 , 6 , 7 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 4 , 15 , 16 , 11 , 13 , 17 , 17 , 18 , 19 , 4 , 5 , 6 , 20 , 14 , 21 , 22 , 16 , 23 , 24 , 10 , 18 , 12 , 25 , 11 , 15 , 26 , 13 , 27 , 14 , 4 , 18 , 28 , 19 , 29 , 12 , 30 , 23 , 31 , 30 , 11 , 25 , 27 , 28 , 29 , 7 , 4 , 5 , 6
      Journal of Neuropathology & Experimental Neurology
      Oxford University Press (OUP)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Primary age-related tauopathy (PART) is a neurodegenerative entity defined as Alzheimer-type neurofibrillary degeneration primarily affecting the medial temporal lobe with minimal to absent amyloid-β (Aβ) plaque deposition. The extent to which PART can be differentiated pathoanatomically from Alzheimer disease (AD) is unclear. Here, we examined the regional distribution of tau pathology in a large cohort of postmortem brains (n = 914). We found an early vulnerability of the CA2 subregion of the hippocampus to neurofibrillary degeneration in PART, and semiquantitative assessment of neurofibrillary degeneration in CA2 was significantly greater than in CA1 in PART. In contrast, subjects harboring intermediate-to-high AD neuropathologic change (ADNC) displayed relative sparing of CA2 until later stages of their disease course. In addition, the CA2/CA1 ratio of neurofibrillary degeneration in PART was significantly higher than in subjects with intermediate-to-high ADNC burden. Furthermore, the distribution of tau pathology in PART diverges from the Braak NFT staging system and Braak stage does not correlate with cognitive function in PART as it does in individuals with intermediate-to-high ADNC. These findings highlight the need for a better understanding of the contribution of PART to cognitive impairment and how neurofibrillary degeneration interacts with Aβ pathology in AD and PART.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Neuropathological stageing of Alzheimer-related changes

          Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes. The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages. Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads. The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another. Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages. The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II). The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex. In addition, there was mild involvement of the first Ammon's horn sector. The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas. The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

            We present a practical guide for the implementation of recently revised National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (AD). Major revisions from previous consensus criteria are: (1) recognition that AD neuropathologic changes may occur in the apparent absence of cognitive impairment, (2) an "ABC" score for AD neuropathologic change that incorporates histopathologic assessments of amyloid β deposits (A), staging of neurofibrillary tangles (B), and scoring of neuritic plaques (C), and (3) more detailed approaches for assessing commonly co-morbid conditions such as Lewy body disease, vascular brain injury, hippocampal sclerosis, and TAR DNA binding protein (TDP)-43 immunoreactive inclusions. Recommendations also are made for the minimum sampling of brain, preferred staining methods with acceptable alternatives, reporting of results, and clinico-pathologic correlations.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Staging of brain pathology related to sporadic Parkinson’s disease

                Bookmark

                Author and article information

                Journal
                Journal of Neuropathology & Experimental Neurology
                Oxford University Press (OUP)
                0022-3069
                1554-6578
                February 01 2021
                January 20 2021
                January 17 2021
                February 01 2021
                January 20 2021
                January 17 2021
                : 80
                : 2
                : 102-111
                Affiliations
                [1 ]From the Department of Pathology, University of Texas Health Science Center, San Antonio, Texas, USA
                [2 ]Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, Texas, USA
                [3 ]Department of Pathology, State University of New York, Upstate Medical University, Syracuse, New York, USA
                [4 ]Department of Pathology and Nash Family Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA
                [5 ]Neuropathology Brain Bank & Research Core, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
                [6 ]Ronald M. Loeb Center for Alzheimer’s Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA
                [7 ]Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
                [8 ]Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom
                [9 ]Department of Neuroscience, Genentech Inc., South San Francisco, California, USA
                [10 ]Neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA
                [11 ]Department of Pathology, Northwestern Cognitive Neurology and Alzheimer Disease Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
                [12 ]Department of Pathology, VA Medical Center & Boston University School of Medicine, Boston, Massachusetts, USA
                [13 ]Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
                [14 ]Institute for Memory Impairments and Neurological Disorders, UC Irvine, Irvine, California, USA
                [15 ]Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA
                [16 ]Department of Laboratory Medicine and Pathobiology, University of Toronto, Laboratory Medicine Program, University Health Network, and Tanz Centre for Research in Neurodegenerative Disease, Krembil Brain Institute, Toronto, Ontario, Canada
                [17 ]Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
                [18 ]Departments of Neurosciences and Pathology, University of California, San Diego, La Jolla, California, USA
                [19 ]Department of Psychiatry and Alzheimer’s Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA
                [20 ]Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA
                [21 ]Department of Pathology, University of Washington, Seattle, Washington, USA
                [22 ]Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
                [23 ]Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
                [24 ]Institute of Neurology, Medical University of Vienna, Vienna, Austria
                [25 ]Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
                [26 ]Department of Pathology and Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA
                [27 ]Department of Pathology, Oregon Health Sciences University, Portland, Oregon, USA
                [28 ]Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
                [29 ]Departments of Pathology and Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
                [30 ]Department of Pathology & Cell Biology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA
                [31 ]Division of Neuropathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
                Article
                10.1093/jnen/nlaa153
                33367843
                4af3c691-441a-41fc-a3a1-7ad8e2f923c6
                © 2021

                https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

                History

                Comments

                Comment on this article